- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07332585
Efficacy of Piezosurgery Versus Conventional Osteotomy in Prelacrimal Approach Targeting Different Maxillary Sinus Pathologies (prelacrimal)
December 30, 2025 updated by: Mansoura University
Efficacy of Piezosurgery Versus Conventional Osteotomy in Prelacrimal Approach Targeting Different Maxillary Sinus Pathologies: a Randomized Controlled Trial
The prelacrimal recess approach is a minimally invasive approach to maxillary sinus lesions.
The current study aimed to evaluate the efficacy of piezosurgery versus conventional osteotomy while performing a prelacrimal apporach.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Dakahlia Governorate
-
Al Mansurah, Dakahlia Governorate, Egypt, 35511
- Faculty of Medicine, Mansoura University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Any maxillary sinus pathology (recurrent Antrochoanal polyp, inverted papilloma, fungal ball, allergic fungal sinusitis, CRSwNP, CRSeNP, orbital floor fracture, etc).
- Favorable prelacrimal recess (Type II or III Simmen classification)
- Age> 18 years.
- No gender limitation.
Exclusion Criteria:
- patients with malignant sino-nasal tumors.
- patients unfit for surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: piezosurgery group
|
The removal of the bone in the prelacrimal approach was done using piezo ultrasonic device
|
|
Active Comparator: conventional osteotomy group
|
The removal of the bone in the prelacrimal approach was done using conventional osteotome and hammer
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intraoperative bleeding
Time Frame: During the surgical procedure
|
The amount of blood collected in the suction device
|
During the surgical procedure
|
|
Operative time
Time Frame: During the surgical procedure
|
the time of surgical procedure
|
During the surgical procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative hyposthesia
Time Frame: six months after surgery
|
hyposthesia in the cheek and upper teeth after surgery, measured by the Barrow Institution grading of hyposthesia
|
six months after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2024
Primary Completion (Actual)
November 30, 2025
Study Completion (Actual)
November 30, 2025
Study Registration Dates
First Submitted
December 30, 2025
First Submitted That Met QC Criteria
December 30, 2025
First Posted (Estimated)
January 12, 2026
Study Record Updates
Last Update Posted (Estimated)
January 12, 2026
Last Update Submitted That Met QC Criteria
December 30, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- MS.24.11.2964
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Maxillary Sinus Disease
-
Cairo UniversityCompletedDental Implant | Maxillary Sinus | Maxillary Sinus Lift | Maxillary Sinus ElevationEgypt
-
Mashhad University of Medical SciencesCompletedDisorder of Maxillary Sinus | Maxillary Sinus Floor AugmentationIran, Islamic Republic of
-
The Dental Hospital of Zhejiang University School...RecruitingSinus Floor Augmentation | Maxillary SinusChina
-
Kırıkkale UniversityCompleted
-
Cairo UniversityUnknown
-
University of Sao PauloCompleted
-
Cairo UniversityUnknownMaxillary Sinus
-
Tokat Gaziosmanpasa UniversityCompletedMaxillary Sinus Augmentation | Posterior Maxillary AtrophyTurkey (Türkiye)
-
University of MinnesotaNovaBone Products, LLCCompletedSinus Floor Augmentation | Maxillary SinusUnited States
-
Marmara UniversityCompletedMaxillary Sinus Augmentation | Posterior Maxillary AtrophyTurkey (Türkiye)
Clinical Trials on piezo-assisted prelacrimal apporach
-
Haseki Training and Research HospitalRecruitingSeptum; Deviation, Congenital | Nasal Deformity, AcquiredTurkey
-
Dr. France LAMBERTCompletedTooth Overcrowding